Abstract
Cardiovascular disease is the leading cause of death in the United States and developing world. Experimental and clinical studies have demonstrated that a number of interventions including brief periods of ischemia or hypoxia and certain endogenous factors such as opioids, bradykinin, growth factors or pharmacological agents are capable of protecting the heart against post-ischemic contractile dysfunction, arrhythmias and myocardial infarction. This conventional cardioprotection occurs via an autocrine or paracrine action in which these protective factors are released from the heart to act upon itself. Over the last ten years, a growing body of evidence indicates that a brief ischemic insult on one organ releases endogenous factors that protect other organs against a prolonged ischemic insult. This phenomenon, termed remote preconditioning or preconditioning at a distance, implicates an endocrine action, and may involve humoral or neuralendocrine signaling. This review will summarize the endocrine factors identified and implicated in this inter-organ cytoprotection.
Keywords: Remote preconditioning, humoral, neurogenic, ischemia-reperfusion injury, endocrine factors, experimental studies, clinical studies
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title: Remote Preconditioning- Endocrine Factors in Organ Protection Against Ischemic Injury
Volume: 7 Issue: 3
Author(s): Craig S. Bolte, Siyun Liao, Garrett J. Gross and Jo El J. Schultz
Affiliation:
Keywords: Remote preconditioning, humoral, neurogenic, ischemia-reperfusion injury, endocrine factors, experimental studies, clinical studies
Abstract: Cardiovascular disease is the leading cause of death in the United States and developing world. Experimental and clinical studies have demonstrated that a number of interventions including brief periods of ischemia or hypoxia and certain endogenous factors such as opioids, bradykinin, growth factors or pharmacological agents are capable of protecting the heart against post-ischemic contractile dysfunction, arrhythmias and myocardial infarction. This conventional cardioprotection occurs via an autocrine or paracrine action in which these protective factors are released from the heart to act upon itself. Over the last ten years, a growing body of evidence indicates that a brief ischemic insult on one organ releases endogenous factors that protect other organs against a prolonged ischemic insult. This phenomenon, termed remote preconditioning or preconditioning at a distance, implicates an endocrine action, and may involve humoral or neuralendocrine signaling. This review will summarize the endocrine factors identified and implicated in this inter-organ cytoprotection.
Export Options
About this article
Cite this article as:
Bolte S. Craig, Liao Siyun, Gross J. Garrett and Schultz J. Jo El, Remote Preconditioning- Endocrine Factors in Organ Protection Against Ischemic Injury, Endocrine, Metabolic & Immune Disorders - Drug Targets 2007; 7 (3) . https://dx.doi.org/10.2174/187153007781662585
DOI https://dx.doi.org/10.2174/187153007781662585 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Melatonin, a Potential Therapeutic Agent for Smooth Muscle-Related Pathological Conditions and Aging
Current Medicinal Chemistry Wip1-Deficient Neutrophils Significantly Promote Intestinal Ischemia/Reperfusion Injury in Mice
Current Molecular Medicine Cardiovascular Magnetic Resonance Imaging: State of the Art
Current Cardiology Reviews Recommendations for the Treatment of Hypertension in Elderly People
Cardiovascular & Hematological Agents in Medicinal Chemistry Soluble Epoxide Hydrolase Inhibitors and their Potential for Treatment of Multiple Pathologic Conditions
Current Medicinal Chemistry Vitamin D Therapy in Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design Conductance and Resistance Vessels in Arterial Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Studies on Chloride Channels and their Modulators
Current Topics in Medicinal Chemistry Spontaneous Coronary Artery Dissection: Does Being Unemployed Matter? Insights from the GSCAD Registry
Current Cardiology Reviews ATP-Sensitive Potassium Channels
Current Pharmaceutical Design Immune Mechanisms and Novel Pharmacological Therapies of Acute Kidney Injury
Current Drug Targets Potential Approaches to Enhance the Effects of Estrogen on Senescent Blood Vessels and Postmenopausal Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Tyrphostins as Potential Therapeutic Agents for Acute Kidney Injury
Current Medicinal Chemistry Clinical Pharmacology of Ibuprofen and Indomethacin in Preterm Infants with Patent Ductus Arteriosus
Current Pediatric Reviews Treatment of Diabetic Foot Ulcer: An Overview Strategies for Clinical Approach
Current Diabetes Reviews Role of the Decreased Nitric Oxide Bioavailability in the Vascular Complications of Diabetes Mellitus
Current Pharmaceutical Biotechnology Common and Less Common Peripheral Nerve Disorders Associated with Diabetes
Current Diabetes Reviews TNF-α/Cycloheximide-Induced Oxidative Stress and Apoptosis in Murine Intestinal Epithelial MODE-K Cells
Current Pharmaceutical Design Protease-Activated Receptors as Therapeutic Targets in Visceral Pain
Current Neuropharmacology Transcriptional Regulation of Antimicrobial Host Defense Peptides
Current Protein & Peptide Science